macroline

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Kam, Toh-Seok: 1 article (11/2019)
2.	Lim, Siew-Huah: 1 article (11/2019)
3.	Low, Yun-Yee: 1 article (11/2019)
4.	Saad, Hazwani Mat: 1 article (11/2019)
5.	Sim, Kae-Shin: 1 article (11/2019)
6.	Tan, Chun-Hoe: 1 article (11/2019)
7.	Yeap, Joanne Soon-Yee: 1 article (11/2019)
8.	Carcache de Blanco, Esperanza J: 1 article (12/2014)
9.	Chai, Heebyung: 1 article (12/2014)
10.	Kinghorn, A Douglas: 1 article (12/2014)

1.	Neoplasms (Cancer) 11/22/2019 - "The macroline-sarpagine alkaloids (1-6) showed in vitro growth inhibitory activity against a panel of human cancer cell lines, inclusive of KB, vincristine-resistant KB, PC-3, LNCaP, MCF7, MDA-MB-231, HT-29, HCT 116, and A549 cells (IC50 values: 0.02-9.0 μM)."
2.	Colonic Neoplasms (Colon Cancer) 12/01/2014 - "Bioassay-guided fractionation was conducted on a CHCl3-soluble extract of the stem bark of Alstonia angustifolia (Apocynaceae) collected in Vietnam using the HT-29 human colon cancer cell line, and led to the isolation of a new sarpagine-type indole alkaloid (1), together with nine known alkaloids, including four macroline-derived alkaloids (2-5), a sarpagine-type alkaloid (6), and four macroline-pleiocarpamine bisindole alkaloids (7-10). "